Table of Contents
Chapter 1 Ivd Quality Control Market: Research Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Definitions
1.1.1.1 Application Segment
1.1.1.2 Type Segment
1.1.1.3 End Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Ivd Quality Control Market: Executive Summary
2.1 Market Outlook
2.2 Application And Type Snapshot
2.3 End Use Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Ivd Quality Control Market: Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Rising Number Of Accredited Clinical Laboratories
3.2.1.2. Increasing Third-Party Quality Control Services
3.2.1.3. Presence Of Favorable Regulatory Bodies
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Ivd Quality Control Services
3.2.2.2 Unfavorable Scenario Of Reimbursement In Ivd Industry
3.3 Industry Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Pestel Analysis
3.3.3 Covid-19 Impact Analysis
Chapter 4 Ivd Quality Control Market: Application Business Analysis
4.1 Ivd Quality Control Market: Application Movement Analysis
4.2 Immunoassay
4.2.1 Immunoassay Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Hematology
4.3.1 Hematology Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Clinical Chemistry
4.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Molecular Diagnostics
4.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.6 Coagulation
4.6.1 Coagulation Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.7 Microbiology
4.7.1 Microbiology Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.8 Others
4.8.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Ivd Quality Control Market: Type Business Analysis
5.1 Ivd Quality Control Market: Type Movement Analysis
5.2 Quality Control
5.2.1 Quality Control Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.1.1 By Type
5.2.1.2 Plasma-Based Control
5.2.1.2.1 Plasma-Based Control Market, 2018 – 2030 (USD Million)
5.2.1.3 Serum-Based Control
5.2.1.3.1 Serum-Based Control Market, 2018 – 2030 (USD Million)
5.2.1.4 Whole Blood-Based Control
5.2.1.4.1 Whole Blood-Based Control Market, 2018 – 2030 (USD Million)
5.2.1.5 Others
5.2.1.5.1 Others Market, 2018 – 2030 (USD Million)
5.2.2.1 By Application
5.2.2.2 Immunochemistry
5.2.2.2.2 Immunochemistry Market, 2018 – 2030 (USD Million)
5.2.2.3 Hematology
5.2.2.2.3 Hematology Market, 2018 – 2030 (USD Million)
5.2.2.4 Clinical Chemistry
5.2.2.2.4 Clinical Chemistry Market, 2018 – 2030 (USD Million)
5.2.2.5 Molecular Diagnostics
5.2.2.2.5 Molecular Diagnostics Market, 2018 – 2030 (USD Million)
5.2.2.6 Coagulation
5.2.2.2.6 Coagulation Market, 2018 – 2030 (USD Million)
5.2.2.7 Microbiology
5.2.2.2.7 Microbiology Market, 2018 – 2030 (USD Million)
5.2.2.8 Others
5.2.2.2.8 Others Market, 2018 – 2030 (USD Million)
5.3 Quality Assurance Services
5.3.1 Immunochemistry
5.3.1.1 Immunochemistry Market, 2018 – 2030 (USD Million)
5.3.2 Hematology
5.3.2.1 Hematology Market, 2018 – 2030 (USD Million)
5.3.3 Clinical Chemistry
5.3.3.1 Clinical Chemistry Market, 2018 – 2030 (USD Million)
5.3.4 Molecular Diagnostics
5.3.4.1 Molecular Diagnostics Market, 2018 – 2030 (USD Million)
5.3.5 Coagulation
5.3.5.1 Coagulation Market, 2018 – 2030 (USD Million)
5.3.6 Microbiology
5.3.6.1 Microbiology Market, 2018 – 2030 (USD Million)
5.3.7 Others
5.3.7.1 Others Market, 2018 – 2030 (USD Million)
5.4 Data Management Solutions
5.4.1 Immunochemistry
5.4.1.1 Immunochemistry Market, 2018 – 2030 (USD Million)
5.4.2 Hematology
5.4.2.1 Hematology Market, 2018 – 2030 (USD Million)
5.4.3 Clinical Chemistry
5.4.3.1 Clinical Chemistry Market, 2018 – 2030 (USD Million)
5.4.4 Molecular Diagnostics
5.4.4.1 Molecular Diagnostics Market, 2018 – 2030 (USD Million)
5.4.5 Coagulation
5.4.5.1 Coagulation Market, 2018 – 2030 (USD Million)
5.4.6 Microbiology
5.4.6.1 Microbiology Market, 2018 – 2030 (USD Million)
5.4.7 Others
5.4.7.1 Others Market, 2018 – 2030 (USD Million)
Chapter 6 Ivd Quality Control Market: End-Use Business Analysis
6.1 Ivd Quality Control Market: End-Use Movement Analysis
6.2 Home Care
6.2.1 Home Care Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Laboratory
6.3.1 Laboratory Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Hospitals
6.4.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Ivd Quality Control Market: Regional Business Analysis
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Ivd Quality Control Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.2 Uk
7.3.2.1 Uk Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.4 Spain
7.3.4.1 Spain Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.5 France
7.3.5.1 France Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.6 Italy
7.3.6.1 Italy Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Denmark Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Sweden Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia-Pacific Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.4 India
7.4.4.1 India Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.5 South Korea
7.4.5.1 South Korea Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Thailand Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.7 Australia
7.4.7.1 Australia Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.3 Mexico
7.5.3.1 Mexico Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.4 Argentina
7.5.4.1 Argentina Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.5.4.2 Key Country Dynamics
7.5.4.3 Regulatory Framework
7.5.4.4 Reimbursement Scenario
7.6 MEA
7.6.1 MEA Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 UAE Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Ivd Quality Control Market, 2018 – 2030 (USD Million)
7.6.5.2 Key Country Dynamics
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario
Chapter 8 Ivd Quality Control Market: Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Siemens Healthcare
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 Abbott Diagnostics, Inc
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Bio-Rad Laboratories, Inc.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Danaher Corporation
8.4.4.1 Company Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 Roche Diagnostics
8.4.5.1 Company Overview
8.4.5.2 Financial Performance
8.4.5.3 Product Benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 Sysmex Corporation
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Sero As
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 Thermo Fisher Scientific, Inc
8.4.8.1 Company Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 Sun Diagnostics, Llc
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.4 Product Benchmarking
8.4.9.5 Strategic Initiatives
8.4.10 Ortho Clinical Diagnostics, Inc.
8.4.10.1 Company Overview
8.4.10.2 Financial Performance
8.4.10.3 Product Benchmarking
8.4.10.4 Strategic Initiatives
8.4.11 Randox Laboratories Ltd
8.4.11.1 Company Overview
8.4.11.2 Financial Performance
8.4.11.3 Product Benchmarking
8.4.11.4 Strategic Initiatives
8.4.12 Helena Laboratories Corporation
8.4.12.1 Company Overview
8.4.12.2 Financial Performance
8.4.12.3 Product Benchmarking
8.4.12.4 Strategic Initiatives
8.4.13 Seracare Life Sciences, Inc
8.4.13.1 Company Overview
8.4.13.2 Financial Performance
8.4.13.3 Product Benchmarking
8.4.13.4 Strategic Initiatives
8.4.14 Technopath Clinical Diagnostics
8.4.14.1 Company Overview
8.4.14.2 Financial Performance
8.4.14.3 Product Benchmarking
8.4.14.4 Strategic Initiatives
Chapter 9 Kol Recommendations/Analyst Perspective
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/